German Cancer Research Center, Heidelberg, Germany.
Int J Cancer. 2010 Jul 15;127(2):442-51. doi: 10.1002/ijc.25050.
Endometrial cancer risk has been associated with reproductive factors (age at menarche, age at menopause, parity, age at first and last birth, time since last birth and use of oral contraceptives (OCs)]. However, these factors are closely interrelated and whether they act independently still requires clarification. We conducted a study to examine the association of menstrual and reproductive variables with the risk of endometrial cancer among the European Prospective Investigation into Cancer and Nutrition (EPIC). Among the 302,618 women eligible for the study, 1,017 incident endometrial cancer cases were identified. A reduction in endometrial cancer risk was observed in women with late menarche, early menopause, past OC use, high parity and a shorter time since last full-term pregnancy (FTP). No association was observed for duration of breast feeding after adjustment for number of FTP or for abortion (spontaneous or induced). After mutual adjustment, late age at menarche, early age at menopause and duration of OC use showed similar risk reductions of 7-8% per year of menstrual life, whereas the decreased risk associated with cumulative duration of FTPs was stronger (22% per year). In conclusion, our findings confirmed a reduction in risk of endometrial cancer with factors associated with a lower cumulative exposure to estrogen and/or higher exposure to progesterone, such as increasing number of FTPs and shorter menstrual lifespan and, therefore, support an important role of hormonal mechanisms in endometrial carcinogenesis.
子宫内膜癌的风险与生殖因素(初潮年龄、绝经年龄、产次、首次和末次生育年龄、上次生育后时间和口服避孕药(OC)的使用)有关。然而,这些因素密切相关,它们是否独立起作用仍需澄清。我们进行了一项研究,以检查欧洲癌症与营养前瞻性调查(EPIC)中月经和生殖变量与子宫内膜癌风险的关系。在符合研究条件的 302618 名女性中,确定了 1017 例子宫内膜癌新发病例。在初潮晚、绝经早、过去使用 OC、多产和上次足月妊娠后时间较短的女性中,子宫内膜癌的风险降低。在调整 FTP 数量或流产(自然或人工)后,母乳喂养时间与子宫内膜癌风险无关。相互调整后,初潮年龄晚、绝经年龄早和 OC 使用时间与每年月经生活的风险降低 7-8%相似,而与累积 FTP 持续时间相关的风险降低更强(每年 22%)。总之,我们的研究结果证实了与雌激素累积暴露降低和/或孕激素暴露增加相关的因素可降低子宫内膜癌的风险,例如增加产次和缩短月经周期,因此支持激素机制在子宫内膜癌发生中的重要作用。